FGFR1 and HER1 or HER2 co‑amplification in breast cancer indicate poor prognosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

FGFR1 and HER1 or HER2 co‑amplification in breast cancer indicate poor prognosis

Published:2018-04-04 Issue: Volume: Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Chen Shinan¹,Qiu Yan¹,Guo Peng¹,Pu Tianjie¹,Feng Ye¹,Bu Hong¹

Affiliation:

1. Laboratory of Pathology, West China Hospital, Sichuan University, Chengdu, Sichuan 610000, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transfer Learning in Cancer Genetics, Mutation Detection, Gene Expression Analysis, and Syndrome Recognition;Cancers;2024-06-04

2. The diverse dependence of galectin-1 and -8 on multivalency for the modulation of FGFR1 endocytosis;Cell Communication and Signaling;2024-05-15

3. Targeting HER2 and FGFR-positive cancer cells with a bispecific cytotoxic conjugate combining anti-HER2 Affibody and FGF2;International Journal of Biological Macromolecules;2024-01

4. CCDC86 promotes the aggressive behavior of nasopharyngeal carcinoma by positively regulating EGFR and activating the PI3K/Akt signaling;Neoplasma;2024

5. Clinical Impact of 11q13.3 Amplification on Immune Cell Infiltration and Prognosis in Breast Cancer;International Journal of General Medicine;2022-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP